Clinical Trial Update: A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer [Phase 3]

View source ↗

Summary

A randomized Phase III trial comparing FLAC chemotherapy with GM-CSF to PIXY 321 in advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Leucovorin (folinic acid)
• PIXY 321

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Neoplasms, Fever | Phase 3 | Status: COMPLETED